Chromatographia

, Volume 16, Issue 1, pp 112–116 | Cite as

Neurochemical studies on catecholamines and indoleamines by high-performance liquid chromatography with electrochemical detection

  • J. M. Tusell
  • C. Suñol
  • F. Artigas
  • E. Martínez
  • E. Gelpí
Originals

Summary

This communication reports the HPLC separation and quantitative ECD assay of dopamine (DA) and its metabolites DOPAC and HVA, 5-HT and its metabolite 5-HIAA and the noradrenaline metabolites MHPG and VMA, in samples of rat brain extracts and human CSF. The separation is carried out by reversed-phase with a methanolic phosphate/citrate buffer as mobile phase. Response is linear within 10pg-20 ng. Rat brain homogenates of cortex plus striatum were centrifuged and 10–20 μl aliquots injected in the column. CSF samples were directly injected without any further manipulation. The method has been applied to the study of the possible neuromodulating role of T on the catecholaminergic and serotonergic transmission. For this purpose rats are injected intraperitoneally (ip) with T (150 mg/kg) and killed after 30 min. Relative to control rats, the results show that for n=12, T does not affect the basal level of DA and DOPAC whereas HVA increases a 99.3% and 5HT and 5HIAA show variations of 23% and — 4.1%, respectively. Aside from the fall of 5HIAA, it is interesting to note that the turnover rate of 5HT decreases, which might prove of functional significance.

Key Words

Reversed-phase HPLC Electrochemical detection Catecholamine and serotonine metabolism Tryptamine effect in CNS 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Neuropharmacology of central nervous system and behavioral disorders. Ed.G. C. Palmer; Academic Press Inc. New York, 1980.Google Scholar
  2. [2]
    Pharmacology and biochemistry of psychiatric disorders. Ed.A. R. Green andD. W. Costain; John Wiley & Sons Ltd. New York, 1981.Google Scholar
  3. [3]
    Handbook of studies on depression. Ed.G. D. Burrows; Excepta medica, Amsterdam, 1977.Google Scholar
  4. [4]
    E. Gelpi, Gas Chromatographic Mass Spectrometric analysis of biogenic amines in “Analysis of Biogenic Amines”. Ed.G. Baker andR. Coutts. Elsevier Scientific Pub. Co. Amsterdam (1982) p. 151.Google Scholar
  5. [5]
    J. Segura, F. Artigas, E. Martínez, E. Gelpí, Biom. Mass Spectrom.3, 91 (1976).Google Scholar
  6. [6]
    F. Artigas, E. Gelpí, Anal. Biochem.92, 233 (1979).Google Scholar
  7. [7]
    G. Curzon, B. D. Kantamaneni, M. D. Tricklebank, Br. J. Pharmac.73, 555 (1981).Google Scholar
  8. [8]
    E. Kempf, P. Mandel, Anal. Biochem.112, 223 (1981).Google Scholar
  9. [9]
    F. Artigas, E. Martínez, E. Gelpí, J. Chromatogr. Sci.20, 75 (1982).Google Scholar
  10. [10]
    E. Martínez, J. M. Tusell, C. Suñol, N. Mahy, F. Artigas, E. Gelpi in “Biological/Biomedical Applications of Liquid Chromatography IV”. Ed.G. L. Hawk, Marcel Dekker Inc. New York, 1982, p. 305.Google Scholar
  11. [11]
    A. M. Krstulovic, L. Bertani-Dziedzic, S. Bautista-Cerqueira, S. E. Gitlow, J. Chromatogr.227, 379 (1982).Google Scholar
  12. [12]
    M. H. Joseph, B. V. Kadam, D. Risby, J. Chromatogr.226, 361 (1981).Google Scholar
  13. [13]
    L. R. Hegstrand, B. Eichelman, J. Chromatogr.222, 107 (1981).Google Scholar
  14. [14]
    H. Snendsen, T. Greibrokk, J. Chromatogr.213, 429 (1981).Google Scholar
  15. [15]
    O. Magnusson, L. B. Nilsson, D. Westerlund, J. Chromatogr.221 237 (1980).Google Scholar
  16. [16]
    G. M. Anderson, J. G. Young, D. K. Batter, S. N. Young, D. I. Cohen, B. A. Shaywitz, J. Chromatogr.223, 315 (1981).Google Scholar
  17. [17]
    C. D. Kilts, G. R. Breese, R. B. Mailnan J. Chromatogr.225, 347 (1981).Google Scholar
  18. [18]
    L. Smerdjian-Rouquier, L. Bossi, B. Scatton, J. Chromatogr.218, 663 (1981).Google Scholar
  19. [19]
    J. J. Warsh, A. Chiu, D. D. Godse, J. Chromatogr.228, 131 (1982).Google Scholar
  20. [20]
    C. Suñol, J. M. Tusell, E. Martínez, F. Actigas, E. Gelpí, in preparation.Google Scholar
  21. [21]
    T. P. Davis, C. W. Gehrke Jr., C. H. Williams, C. W. Gehrke, K. O. Gerhardt, J. Chromatogr.228, 113 (1982).Google Scholar
  22. [22]
    J. Wagner, M. Palfreyman, M. Zraika, J. Chromatogr.164, 41 (1979).Google Scholar
  23. [23]
    T. P. Moyer, N. S. Jiang, J. Chromatogr.153, 365 (1978).Google Scholar
  24. [24]
    W. H. Vogel, I. Cohen, Brain Res.122, 162 (1977).Google Scholar
  25. [25]
    A. Adell, J. M. Tusell, F. Artigas, E. Martínez, C. Suñol, E. Gelpi. J. Liquid Chromatog. In press.Google Scholar
  26. [26]
    C. A. Marsden, G. Curzon, Neuropharmacology18, 159 (1979).Google Scholar
  27. [27]
    R. S. G. Jones, A. A. Boulton, Life Sci.27, 1849 (1980).Google Scholar
  28. [28]
    R. S. G. Jones, Br. J. Pharmac.73, 485 (1981).Google Scholar
  29. [29]
    B. Cox, T. F. Lee, D. Martin, Br. J. Pharmac.72, 477 (1981).Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1982

Authors and Affiliations

  • J. M. Tusell
    • 1
  • C. Suñol
    • 1
  • F. Artigas
    • 1
  • E. Martínez
    • 1
  • E. Gelpí
    • 1
  1. 1.Analytical Neurochemistry UnitInstituto de Quimica Bio-Orgánica, C.S.I.C. c/Jorge Girona Salgado, s/nBarcelonaSpain

Personalised recommendations